Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUST Trial Follow-up Study
2011-001078-25Phase 3Completed
- Sponsor
- National Institutes of Health
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in non-infectious intermediate uveitis, Posterior uveitis (non-infectious), non-infectious panuveitis (NIU), sponsored by National Institutes of Health. Started Nov 2011; status: completed.
02
Drugs
fluocinolone
03
Conditions
non-infectious intermediate uveitisPosterior uveitis (non-infectious)non-infectious panuveitis (NIU)
Beyond the preview
Go deeper on 2011-001078-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001078-25.